Endo International | Passività Correnti



Passività Correnti Cambiamento Data
AbbVie USD 39.39B 376M 2025-09
Amarin USD 182.23M 3.71M 2025-09
ANI Pharmaceuticals USD 270.56M 33.72M 2025-09
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Coherus Biosciences USD 372.3M 108.67M 2025-09
Eli Lilly USD 40.14B 1.12B 2025-09
Heron Therapeutics USD 89.71M 168.89M 2025-09
Hikma Pharmaceutical USD 2.06B 78M 2025-06
Ligand Pharmaceuticals USD 30.54M 34.2M 2025-09
Merck USD 28.63B 2.59B 2025-09
Novartis USD 32B 286M 2025-09
Pacira USD 107.08M 206.09M 2025-09
Perrigo USD 1.15B 19.2M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Phibro Animal Health USD 282.37M 12.23M 2025-12
Supernus Pharmaceuticals USD 330.63M 44.27M 2025-09
Takeda JPY 2.61T 470.53B 2025-12
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12
Xeris Pharmaceuticals USD 116.2M 21.03M 2025-09
Zoetis USD 1.81B 1.56B 2025-09


Endo International Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.